Jefferies raises American Airlines stock price target on revenue growth By Investing.com

American Airlines drew multiple analyst target hikes, including Jefferies to $13 from $12 and BMO to $13.50 from $12, after first-quarter revenue of $13.91 billion beat estimates and the EPS loss of $0.40 was better than the expected $0.47 loss. Management signaled 7.6% unit revenue growth in Q1, 9.5% to 10.5% unit revenue growth in Q2, and about 4% capacity growth for the year, while shifting $300 million of delivery capex out of 2026. Sentiment is mixed but slightly constructive given improving revenue trends and margin progress, offset by cautious capacity commentary and still-soft earnings expectations.

Analysis

The market is rewarding AAL less for current earnings than for a narrowing credibility gap: management is showing enough pricing power and cost discipline to keep the equity in the ‘re-rating candidate’ bucket, but not enough to justify an outright quality premium. The key second-order effect is capacity restraint elsewhere; if peers stay rational, AAL’s incremental unit revenue improvement can persist longer than the market expects, because airline pricing is a function of industry seat growth, not just one carrier’s execution.

The biggest swing factor is not the quarter itself but the next two booking cycles. AAL’s valuation still embeds a meaningful skepticism discount, so even modest confirmation that domestic yields are stabilizing could drive the stock toward the low-mid teens. However, if macro softens further, the market will focus on leverage to fuel and the risk that the recent margin improvement is mostly timing rather than durable mix improvement.

From a competitive standpoint, the announcement of deferred capex is quietly important: it signals a more defensive balance-sheet posture and may force a slower fleet refresh, which can help near-term cash flow but risks ceding long-run unit cost advantage versus better-capitalized peers. That tradeoff makes AAL a tactical rather than structural long, with the setup most attractive into pullbacks if capacity commentary from the broader industry remains disciplined. The contrarian read is that consensus is still too anchored to last quarter’s beat; the real upside is if management walks guidance upward again without needing a broader macro tailwind.

Key Decisions for Investors

• Tactically long AAL for 4-8 weeks on weakness below $12.00, targeting $13.50-$14.00; thesis is further multiple recovery if unit revenue commentary holds and peers keep capacity rational.
• Use AAL Jan-2026 $13 calls instead of common for upside exposure; limited premium risk suits a name where the fundamental improvement is real but macro-sensitive.
• Pair trade: long AAL / short JBLU or another weaker U.S. carrier over the next 1-2 quarters; AAL has the cleaner revenue and margin repair story, while weaker peers are more exposed if demand softens.
• If AAL rallies through $13.50 on no new guidance lift, trim aggressively; upside beyond that likely requires either industry capacity discipline or an improved macro backdrop, not just laggard catch-up.